Home/ Stocks/ FLNA

Filana Therapeutics, Inc. Common Stock

FLNA XNAS

$1.30 -0.06 (-4.41%) ▼ 15-min delayed

Open

$1.35

High

$1.35

Low

$1.27

Volume

420.5K

Market Cap

$62.80M

About Filana Therapeutics, Inc. Common Stock

Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 20 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$0	$-10,331,000	$-0.21

Related Market News

No specific coverage for FLNA yet. Check out our latest market news or earnings calendar.

Get FLNA Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Filana Therapeutics, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.